Application of tofacitinib citrate in the treatment of Takayasu arteritis
A technology of tofacitinib and Takayasu, applied in the field of application of tofacitinib citrate in the treatment of Takayasu, which can solve the problems of unsatisfactory long-term effect, high cost and high risk
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0012] Example 1 Application of Tofacitinib Citrate in the Treatment of Takayasu Arteritis
[0013] 1. Materials and methods
[0014] 1.1 Experimental objects and grouping
[0015] Twenty-six TA patients (diagnostic criteria refer to the American College of Rheumatology in 2009: ① age of onset ≤ 40 years old; ② intermittent movement disorder of limbs; ③ weakened brachial artery pulse; ④ systolic pressure difference of both upper extremities > 10 mmHg; Aortic murmur; ⑥Arterial angiography shows stenosis or occlusion of the aorta and its branches or the proximal large arteries of the extremities, and those caused by arteriosclerosis, fibromuscular dysplasia, etc. are excluded. Note: digital subtraction angiography or angiography Vascular stenosis or dilation as the final diagnostic criteria.) Randomly divided into treatment group 16 cases and control group 10 cases, two groups in gender, age, condition and other general clinical data, the difference was not significant ( p >0....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com